OPTIMIZATION OF SOLID-PHASE SYNTHESIS OF [ALA8]-DYNORPHIN-A

[Ala8]-dynorphin A, a potent kappa-selective opioid heptadecapeptide with numerous sensitive side-chain residues, has been prepared by solid-phase synthesis using base-labile N(alpha)-9-fluorenylmethyloxycarbonyl (Fmoc) protection and side-chain anchoring to a tris(alkoxy)benzylamide ''PAL''-resin. Final cleavage and deprotection was carried out with reagent R, trifluoroacetic acid-thioanisole-1,2-ethanedithiol-anisole (90:5:3:2), reagent K, trifluoroacetic acid-phenol-water-thioanisole-1,2-ethanedithiol (82.5:5:5:5:2.5), and reagent B, trifluoroacetic acid-phenol-water-triisopropylsilane (88:5:5:2); optimal reaction and workup conditions are described. Crude peptide products were evaluated by analytical high-performance liquid chromatography (HPLC), capillary zone electrophoresis (CZE), and direct fast atom bombardment and ion electrospray mass spectrometry (FABMS and ESMS). Tryptophan alkylation side reactions involving a 2,4,6-trimethoxybenzyl (Tmob) group from asparagine or 2,2,5,7,8-pentamethylchroman-6-ylsulfonyl (Pmc) groups from arginines occur under insufficiently long cleavage times and/or when certain scavenger components are omitted from the cleavage cocktails, but can be minimized under the best conditions. Conditions with reagent B, 1 h, 25-degrees-C, and extractive workup, were followed up preparatively to provide [Ala8]-dynorphin A in excellent purity (>99%) and 58% overall isolated yield based on the C-terminal amino acid anchored on the resin.